Gerard E. Hogarty (1935--2006): combining science and humanism to improve the care of persons with schizophrenia
- PMID: 17617662
- PMCID: PMC2632347
- DOI: 10.1093/schbul/sbm078
Gerard E. Hogarty (1935--2006): combining science and humanism to improve the care of persons with schizophrenia
Abstract
Gerard E. Hogarty was a scholar and clinician whose career was dedicated to improving the lives of persons with schizophrenia through the rigorous development and testing of novel psychosocial treatment approaches. During the course of his career, he is credited with the development of many of the psychosocial treatments that have become the pillars of evidence-based practices for schizophrenia today. This review outlines the evolution of Hogarty's contributions to the development of psychosocial approaches for schizophrenia by presenting a chronological history of the 4 distinct treatments he developed during the course of his career. These include major role therapy, an early precursor to clinical case management; family psychoeducation, an approach to ally with and educate family members to reduce intrafamilial distress; personal therapy, a flexible, individual psychotherapy, aimed at teaching patients stress management and affective regulation techniques; and finally, cognitive enhancement therapy, a comprehensive, developmental approach to the remediation of social- and nonsocial-cognitive deficits. Each of these treatments built upon the findings of the previous one, and as a consequence, each significantly improved the lives of persons with schizophrenia and expanded the treatment possibilities available to such individuals. These efforts represent a lifelong dedication to advancing the treatment of schizophrenia through rigorous scientific inquiry and exemplify a unique combination of science and humanism that has left a lasting impact on the field and the lives of many individuals suffering from this disease.
Similar articles
-
Remembering Gerard Hogarty.Psychiatr Serv. 2006 Dec;57(12):1677. doi: 10.1176/ps.2006.57.12.1677. Psychiatr Serv. 2006. PMID: 17158479 No abstract available.
-
Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future.Schizophr Res. 2010 Sep;122(1-3):1-23. doi: 10.1016/j.schres.2010.05.025. Epub 2010 Jul 23. Schizophr Res. 2010. PMID: 20655178 Review.
-
Evidence-based psychotherapy for schizophrenia.J Nerv Ment Dis. 2006 Jan;194(1):3-9. doi: 10.1097/01.nmd.0000195316.86036.8a. J Nerv Ment Dis. 2006. PMID: 16462548 Review.
-
Adjunctive psychosocial therapies for the treatment of schizophrenia.Schizophr Res. 2008 Mar;100(1-3):108-19. doi: 10.1016/j.schres.2007.12.468. Epub 2008 Jan 15. Schizophr Res. 2008. PMID: 18226500 Review.
-
Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.Arch Gen Psychiatry. 2004 Sep;61(9):866-76. doi: 10.1001/archpsyc.61.9.866. Arch Gen Psychiatry. 2004. PMID: 15351765 Clinical Trial.
Cited by
-
Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Stratégies pour atteindre une meilleure santé cognitive chez les personnes souffrant du spectre de la schizophrénie : un regard sur le paysage canadien.Can J Psychiatry. 2025 Feb;70(2):85-97. doi: 10.1177/07067437241261928. Epub 2024 Jul 25. Can J Psychiatry. 2025. PMID: 39051555 Free PMC article. Review.
References
-
- Hogarty GE the Collaborative Study Group. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. Arch Gen Psychiatry. 1973;28:54–64. - PubMed
-
- Hogarty GE the Collaborative Study Group. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. Arch Gen Psychiatry. 1974;31:603–608. - PubMed
-
- Hogarty GE, et al. Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study. Arch Gen Psychiatry. 1988;45:797–805. - PubMed
-
- Hogarty GE the Collaborative Study Group. Drug and sociotherapy in the aftercare of schizophrenic patients: III. Adjustment of nonrelapsed patients. Arch Gen Psychiatry. 1974;31:609–618. - PubMed
-
- Brown GW. Influence of family life on the course of schizophrenic illness. Br J Prevent Soc Med. 1962;16:55–68.
Publication types
MeSH terms
Personal name as subject
- Actions